Avatar image

AcouSort AB

Company  | 
Sweden, Lund

About your organization / profile

AcouSort provides solutions for diagnostic applications and cell therapy manufacturing enabling automated and integrated sample processing of cells and extracellular vesicles.

AcouSort’s main strategy is to develop and commercialize Original Equipment Manufacturer (OEM) components for sample preparation and processing. The OEM solutions enable integration of our technology into analytical, diagnostic, and therapeutic systems, providing automated sample preparation. The customer base for the OEM components are instrument manufacturers within the Life Science industry.  

AcouSort intends to expand the portfolio of OEM components to cover a wide range of applications for clinical analysis and handling of biological samples. The Company expects the acoustic separation components to be critical components, essential for development of novel point-of-care testing devices where access to blood plasma or other fractions of blood is required. This also applies for biological sample processing systems in therapeutic settings for e.g., personalized medicine. 

AcouSort’s core technology is acoustofluidics – a combination of sound waves (acousto) and microfluidics. Microfluidics allow for precise control of liquids while acoustics gives us the ability to move particles of different biophysical properties.

By combining the two technologies, we have the unique ability to move target cell types from one liquid to another. This allows us to fractionate the different components in a blood sample, isolate extracellular vesicles or wash cells to remove contaminants, without having any physical contact with the sample.

As the technology is gentle and rapid, it provides a competitive alternative to conventional processing techniques such as centrifugation or filtration. By using acoustofluidics, AcouSort can streamline sample processing for a wide range of applications – from biomarker discovery in basic research, to preparation of clinical blood samples prior to analysis, or sample purification in cell therapy manufacturing.

Network (0)

There are no organizations in the network.

Recent activities

Avatar

AcouSort AB has been awarded the European Innovation Council - Transition beneficiaries  label.

Avatar

AcouSort AB is now a member of the EIC ACCESS+ community.

Avatar

AcouSort AB has published its search for partners online: Enabling automated bio-sample processing for diagnostics, cell therapy and cytometry.

Avatar

Torsten Freltoft has joined AcouSort AB